ERBB2 and neoplasm: CD147 expression is correlated with axillary lymph node involvement, TNM (tumor, node, metastasis) staging and breast cancer HER2 expression based on S-P IHC analysis (p<0.01, p<0.05 and p<0.01, respectively) [22].